Variable | Total | With BOFJ | Without BOFJ | p value (univariate) |
---|---|---|---|---|
n (%) or median (range) | ||||
Patients | 70 | 6 | 64 | |
Preoperative factors | ||||
Age (years) | 68 (46–91) | 64 (52–82) | 69 (46–91) | 0.415* |
Sex | ||||
Male | 65 (93%) | 5 (8%) | 60 (92%) | 0.343† |
Female | 5 (7%) | 1 (20%) | 4 (80%) | |
BMI (kg/m2) | 19 (12–34) | 20 (15–26) | 18 (12–34) | 0.563** |
Serum total protein (mg/dL) | 6.9 (5.7–7.9) | 7.1 (6.3–7.5) | 6.9 (5.7–7.9) | 0.297* |
Serum albumin (mg/dL) | 4 (2.9–4.9) | 4.3 (3.3–4.3) | 4 (2.9–4.9) | 0.735* |
Neoadjuvant chemotherapy | 14 (20%) | 0 | 14 (22%) | 0.200† |
Adjuvant chemotherapy | 50 (71%) | 5 (83%) | 45 (70%) | 0.500† |
Pathological stage | ||||
I | 23 (33%) | 4 (17%) | 19 (83%) | 0.324† |
II | 19 (27%) | 1 (5%) | 18 (95%) | |
III | 26 (37%) | 1 (4%) | 25 (96%) | |
IV | 2 (3%) | 0 | 2 (100%) | |
COPD | 4 (6%) | 1 (25%) | 3 (75%) | 0.227† |
Hypertension | 22 (31%) | 1 (5%) | 21 (95%) | 0.415† |
Current smoker | 40 (57%) | 5 (13%) | 35 (87%) | 0.175† |
Intraoperative factors | ||||
HALS | 28 | 6 | 22 | 0.002† |
Distance between navel and jejunostomy | ||||
Straight distance (mm) | 66 (37–150) | 117 (101–130) | 63 (37–150) | < 0.001** |
Vertical distance (mm) | 54 (17–135) | 107 (93–120) | 49 (17–135) | < 0.001** |
Horizontal distance (mm) | 39 (14–60) | 48 (40–59) | 37 (14–60) | 0.020** |
Surgical duration (min) | 451 (309–613) | 409 (347–464) | 460 (309–613) | 0.015* |
Estimated blood loss (mL) | 119 (1–1030) | 122 (90–150) | 114 (1–1030) | 0.817** |
Length of button (cm) | 4.0 (3.0–5.0) | 3.5 (3.0–4.0) | 4.0 (3.0–5.0) | 0.773* |